Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Haijiao Zhang; Yusuke Nakauchi; Thomas Köhnke; Melissa Stafford; Daniel Bottomly; Rozario Thomas; Beth Wilmot; Shannon K. McWeeney; Ravindra Majeti; Jeffrey Tyner

doi:10.1038/s43018-020-0103-x

Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

Haijiao Zhang(Oregon Health & Science University), Yusuke Nakauchi(California Institute for Regenerative Medicine), Thomas Köhnke(California Institute for Regenerative Medicine), Melissa Stafford(California Institute for Regenerative Medicine), Daniel Bottomly(Oregon Health & Science University), Rozario Thomas(California Institute for Regenerative Medicine), Beth Wilmot(Oregon Health & Science University), Shannon K. McWeeney(Oregon Health & Science University), Ravindra Majeti(California Institute for Regenerative Medicine), Jeffrey Tyner(Oregon Health & Science University)

Nature Cancer

August 18, 2020

10.1038/s43018-020-0103-x

Cited by 202Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis